Hospira has received approval for Gemcitabine Injection, a solution form of the drug. The solution presentations include 200mg, 1g, and 2g with a concentration of 38mg/mL. The solution form is designed to improve pharmacist convenience and handling safety. Its concentration is the same as the reconstituted strength of the available “freeze-dried” form. The solution eliminates the need for reconstitution.
Gemcitabine is the generic of Gemzar (Lilly), an antineoplastic agent used to treat ovarian, breast, non-small cell lung, and pancreatic cancers.